1,024 material Form 8-K filings that 799 companies we cover made with the SEC in August 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Insperity reported second-quarter 2025 revenue up 3% to $1.7 billion, but swung to a net loss of $5 million, or $(0.14) per diluted share, from net income of $18 million a year earlier. The company said higher-than-expected benefits costs drove the decline and lowered its 2025 guidance.
Q2 2025 revenues rose 3% to $1.7 billion; gross profit fell 14% to $223 million.
Q2 2025 adjusted EBITDA was $32 million and adjusted EPS was $0.26, versus $0.86 in Q2 2024.
Updated full-year 2025 guidance: adjusted EPS of $1.81 to $2.51 and adjusted EBITDA of $170 million to $205 million; Q3 2025 adjusted EPS of $0.06 to $0.49.
On July 31, 2025, Insperity also announced an updated HR solutions portfolio, including Insperity HRScale with Workday, which the company said will be available to early adopter customers in 2026.
Grainger reported second-quarter 2025 sales of $4.6 billion, up 5.6%, and diluted EPS of $9.97, up 4.8% on a reported basis, while its operating margin fell 20 basis points to 14.9%. The company lowered its full-year 2025 adjusted diluted EPS guidance to $38.50-$40.25 from $39.00-$41.50, citing tariff-related headwinds, which matters to shareholders because it reduces the earnings outlook even as the quarter's top-line and per-share results grew.
Q2 2025 net sales were $4.6 billion, up 5.6% (5.1% on a daily, constant currency basis).
Diluted EPS was $9.97, up 4.8% reported and 2.2% adjusted; the company said the increase was driven primarily by fewer shares outstanding.
Full-year 2025 adjusted diluted EPS guidance was lowered to $38.50-$40.25 from $39.00-$41.50 as of May 1, 2025.
Operating cash flow was $377 million, and the company returned $336 million to shareholders through dividends and share repurchases.
Colgate-Palmolive reported second-quarter 2025 net sales of $5,110 million, up 1.0%, and GAAP diluted EPS of $0.91, up 2%, while narrowing its full-year organic sales growth outlook to the low end of 2% to 4%. The company also approved a three-year productivity program with projected pre-tax charges of $200 million to $300 million, which will weigh on reported results through December 31, 2028.
Q2 2025 net sales were $5,110 million, up 1.0%; organic sales rose 1.8%, including a 0.6% negative impact from lower private label pet sales.
GAAP diluted EPS was $0.91, up from $0.89; GAAP gross profit margin fell 50 basis points to 60.1%.
Full-year 2025 organic sales growth is now expected at the low end of 2% to 4%; GAAP EPS is still expected to rise low single digits.
The productivity program carries projected cumulative pre-tax charges of $200 million to $300 million over three years, with substantially all incurred by December 31, 2028, recorded in the Corporate segment.
Oshkosh reported second-quarter 2025 net sales of $2.73 billion, down 4.0% from a year earlier, and GAAP diluted EPS of $3.16 versus $2.56, with adjusted EPS of $3.41 versus $3.34. The company raised its 2025 adjusted EPS expectation to approximately $11.00 and its GAAP EPS expectation to approximately $10.25, while keeping its net sales outlook at about $10.6 billion. The filing also announced a $0.51 quarterly dividend.
Q2 net sales decreased $114.8 million, or 4.0%, to $2.73 billion, mainly on lower Access and Transport volume
Q2 GAAP diluted EPS was $3.16 versus $2.56; adjusted diluted EPS was $3.41 versus $3.34
2025 adjusted EPS expectation raised to approximately $11.00; GAAP EPS expectation approximately $10.25; net sales expectation about $10.6 billion, unchanged
Quarterly dividend of $0.51 per share, payable September 2, 2025 to holders of record August 19, 2025
Church & Dwight reported second-quarter 2025 net sales of $1,506.3 million, down 0.3% from a year earlier, and reported EPS of $0.78 versus $0.99 diluted a year ago. Adjusted EPS of $0.94 exceeded the company's $0.85 outlook, and the company kept its full-year adjusted EPS growth outlook of 0 to 2%, but its Q3 adjusted EPS outlook of $0.72 is down 9% from last year.
Net sales $1,506.3 million, down 0.3%; organic sales up 0.1%, the high end of the company's quarterly outlook
Reported EPS $0.78 versus $0.99 diluted a year earlier; adjusted EPS $0.94 versus the $0.85 outlook
About $51 million of pre-tax charges tied to exiting the Flawless, Spinbrush and Waterpik showerhead businesses, excluded from adjusted earnings
Full-year 2025 adjusted EPS growth outlook of 0 to 2% maintained; Touchland acquisition closed in July
T. Rowe Price reported second-quarter 2025 results on August 1, 2025. Net revenues were $1.72 billion, down 0.6% from a year earlier, while GAAP diluted EPS rose 6.2% to $2.24, helped by higher non-operating income. Adjusted diluted EPS of $2.24 was down 0.9% from $2.26, and the firm had net client outflows of $14.9 billion, so shareholders see mixed headline results.
Net revenues of $1,723.3 million, down 0.6% from $1,733.3 million in Q2 2024
GAAP diluted EPS of $2.24 versus $2.11 a year earlier; adjusted diluted EPS of $2.24 versus $2.26
Operating expenses rose 6.5% to $1,245.0 million, while ending AUM reached $1.68 trillion
Full-year 2025 GAAP effective tax rate estimated at 23.5% to 27.5%
Kimberly-Clark reported second quarter 2025 results, with net sales of $4.2 billion down 1.6% from a year earlier and adjusted diluted EPS of $1.92, down 2.0%. The company also raised its 2025 outlook, although the filing's outlook figures are framed as growth ranges and reflect the divestiture of its PPE business and exit of its US private label diaper business.
Q2 net sales were $4.2 billion, down 1.6%, while organic sales rose 3.9% on 5.0% volume growth.
Diluted EPS was $1.53 versus $1.61 a year earlier; adjusted EPS was $1.92, down 2.0%.
The 2025 outlook was raised; adjusted free cash flow is expected to be about $2 billion in 2025.
LyondellBasell reported second-quarter 2025 net income of $115 million, or $0.34 per diluted share, down from $924 million, or $2.82 per share, in the second quarter of 2024 and from $177 million in the first quarter of 2025. Excluding identified items such as asset write-downs and Cash Improvement Plan costs, EPS was $0.62, up from $0.33 in the first quarter but down from $2.20 a year earlier, and the company returned $536 million to shareholders.
Q2 2025 net income was $115 million ($0.34 per diluted share), versus $924 million ($2.82 per share) in Q2 2024.
Excluding identified items, EPS was $0.62, compared with $0.33 in Q1 2025 and $2.20 in Q2 2024.
Sales and other operating revenues were $7,658 million, versus $7,677 million in Q1 2025 and $8,678 million in Q2 2024.
Third-quarter operating rates are expected to be 85% for North American O&P, 75% for European O&P and 80% for I&D assets.
Ingredion reported second-quarter 2025 diluted EPS of $2.99, up from $2.22 a year earlier, and adjusted EPS of $2.87, flat year over year. Net sales fell 2% to $1.83 billion, while the company raised its full-year 2025 reported EPS guidance to $11.25 to $11.75 and adjusted EPS guidance to $11.10 to $11.60.
Q2 2025 net sales were $1.83 billion, down 2% from $1.88 billion a year earlier.
Q2 operating income rose 13% to $271 million; adjusted operating income was $273 million, up 1%.
Full-year 2025 reported EPS guidance is $11.25 to $11.75, and adjusted EPS guidance is $11.10 to $11.60.
The company cited a mechanical fire that briefly shut down its Chicago plant as a negative factor in the F&II U.S./Canada segment.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.